UAB Ritamum pharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,431,894 |
286,379 |
597,242 |
507,317 |
101,463 |
64.17 |
35.43 |
471,216 |
139,398 |
12,002 |
598,273 |
2023 |
---|
1,140,177 |
228,035 |
366,068 |
310,559 |
62,112 |
68.99 |
27.24 |
466,950 |
115,426 |
17,860 |
563,985 |
2024 |
---|
1,168,280 |
232,725 |
444,618 |
376,364 |
74,973 |
60.71 |
32.22 |
566,844 |
114,884 |
13,134 |
667,934 |
Register and
explore Okredo data2024 |
---|
1,168,280 |
232,725 |
444,618 |
376,364 |
74,973 |
60.71 |
32.22 |
566,844 |
114,884 |
13,134 |
667,934 |
Register and
explore Okredo data2024
Turnover (€)
1,168,280 €2 % *
Sales per employee (€)
232,725 €2 % *
Profit before tax (€)
444,618 €21 % *
Net Profit (€)
376,364 €21 % *
Profit per employee (€)
74,973 €21 % *
Total profitability (%)
60.71 %-12.00 % *
Net profitability (%)
32.22 %18.28 % *
Equity (€)
566,844 €21 % *
Amounts Payable And Liabilities (€)
114,884 €0 % *
Non-current Assets (€)
13,134 €-26 % *
CurrentAssets (€)
667,934 €18 % *